Pulike Biological Engineering, Inc. engages in the research, development, manufacturing and sale of biological products for animals, chemical drugs and Chinese veterinary drugs. Its products include genetic engineering vaccines and multivalent vaccines. The company also provides technical services. Pulike Biological Engineering was founded in 1995 and is headquartered in Luoyang, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company